IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v28y2010i5p429-438.html
   My bibliography  Save this article

Economic Content in Medical Journal Advertisements for Medical Devices and Prescription Drugs

Author

Listed:
  • D. Ackerly
  • Seth Glickman
  • Kevin Schulman

Abstract

Background: Previous studies of economic content in medical journal advertisements have not examined all types of economic content and have not included advertisements for medical devices. Objective: To examine trends in the economic content of medical device and pharmaceutical advertisements in medical journals. Methods: Three reviewers examined pharmaceutical and medical device advertisements in six leading medical journals from 1997 through 2006. Product characteristics, economic claims and evidence to support those claims were evaluated. Results: Economic content appeared in 23.5%(561/2389) of pharmaceutical and device advertisements; 11.9% made market share claims and 12.7% made other economic claims. From 1997 through 2006, the percentage of medical device advertisements containing economic content declined from 26.7% to 6.7% (p=0.02), whereas the percentage of pharmaceutical advertisements containing economic content remained stable (21.6–22.0%; p= 0.99). For pharmaceuticals, price claims declined significantly (15.7-4.2%; p> 0.01) and market share claims increased (2.8–11.5%; p= 0.09), and both consistently presented evidence (83% and 98%, respectively) while other types did not (e.g. 13.5%of formulary claims). Medical device economic claims differed from pharmaceutical economic claims; they made fewer market share claims (1.1% vs 12.8%) but more cost-effectiveness (6.5%vs 0.6%) and reimbursement (4.9% vs 0.8%) claims. Fewer than 2%of device advertisements with economic claims provided supporting evidence. Conclusion: The prevalence and type of economic content in pharmaceutical and device advertisements changed between 1997 and 2006, which may reflect evolving market dynamics, such as changes in reimbursement systems. Furthermore, the lack of supporting evidence in medical device advertisements and pharmaceutical formulary claims are potential areas of concern that require additional scrutiny by regulators and journal editors. Copyright Adis Data Information BV 2010

Suggested Citation

  • D. Ackerly & Seth Glickman & Kevin Schulman, 2010. "Economic Content in Medical Journal Advertisements for Medical Devices and Prescription Drugs," PharmacoEconomics, Springer, vol. 28(5), pages 429-438, May.
    • Handle: RePEc:spr:pharme:v:28:y:2010:i:5:p:429-438
    DOI: 10.2165/11318780-000000000-00000
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.2165/11318780-000000000-00000
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.2165/11318780-000000000-00000?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Gianluca Baio & Laura Magazzini & Claudia Oglialoro & Fabio Pammolli & Massimo Riccaboni, 2005. "Medical Devices: Competitiveness and Impact on Public Health Expenditure," Working Papers CERM 05-2005, Competitività, Regole, Mercati (CERM).
    2. G Michael Allan & Joel Lexchin & Natasha Wiebe, 2007. "Physician Awareness of Drug Cost: A Systematic Review," PLOS Medicine, Public Library of Science, vol. 4(9), pages 1-11, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Kurt Hornschild & Stephan Raab & Jörg-Peter Weiß, 2005. "Die Medizintechnik am Standort Deutschland: Chancen und Risiken durch technologische Innovationen, Auswirkungen auf und durch das nationale Gesundheitssystem sowie potentielle Wachstumsmärkte im Ausla," DIW Berlin: Politikberatung kompakt, DIW Berlin, German Institute for Economic Research, edition 2, volume 10, number pbk10, January.
    2. Steven Simoens, 2009. "Which barriers prevent the efficient use of resources in medical device sectors?," Applied Health Economics and Health Policy, Springer, vol. 7(4), pages 209-217, December.
    3. Fabio Pammolli & Nicola Carmine Salerno, 2006. "Spesa sanitaria, demografia, governance istituzionale - Tra trend storici e proiezioni a lungo termine," Working Papers CERM 02-2006, Competitività, Regole, Mercati (CERM).
    4. Elisabet Rodriguez Llorian & Janelle Mann, 2022. "Exploring the technology–healthcare expenditure nexus: a panel error correction approach," Empirical Economics, Springer, vol. 62(6), pages 3061-3086, June.
    5. G. Crea & A. Cavaliere & A. Cozzi, 2019. "Price discrimination in the Italian medical device industry: an empirical analysis," Economia Politica: Journal of Analytical and Institutional Economics, Springer;Fondazione Edison, vol. 36(2), pages 571-608, July.
    6. G Michael Allan & Christina Korownyk & Kate LaSalle & Ben Vandermeer & Victoria Ma & Douglas Klein & Donna Manca, 2010. "Do Randomized Controlled Trials Discuss Healthcare Costs?," PLOS ONE, Public Library of Science, vol. 5(8), pages 1-5, August.
    7. Gauri Billa & Karan Thakkar & Sarita Jaiswar & Dinesh Dhodi, 2014. "A Cross-Sectional Study to Evaluate the Awareness and Attitudes of Physicians Towards Reducing the Cost of Prescription Drugs, Mumbai," Applied Health Economics and Health Policy, Springer, vol. 12(2), pages 125-137, April.
    8. Barkowski, Scott, 2021. "Physician Response to Prices of Other Physicians: Evidence from a Field Experiment," MPRA Paper 108966, University Library of Munich, Germany.
    9. Stefanie Heinzle, 2012. "Disclosure of Energy Operating Cost Information: A Silver Bullet for Overcoming the Energy-Efficiency Gap?," Journal of Consumer Policy, Springer, vol. 35(1), pages 43-64, March.
    10. Lexchin, Joel, 2009. "Pricing of multiple dosage prescription medications: An analysis of the Ontario Drug Benefit Formulary," Health Policy, Elsevier, vol. 91(2), pages 142-147, July.
    11. Ida Iren Eriksen & Hans Olav Melberg & Berit Bringedal, 2013. "Norwegian Physicians’ Knowledge of the Prices of Pharmaceuticals: A Survey," PLOS ONE, Public Library of Science, vol. 8(9), pages 1-1, September.
    12. Magno, Cielo & Guzman, Ricardo Rafael S., 2019. "Drug price sensitivity among physicians in a developing healthcare system: Evidence from the Philippine market for statins and beta blockers," Economic Analysis and Policy, Elsevier, vol. 62(C), pages 268-279.
    13. Kamil Dybczak & Bartosz Przywara, 2010. "The role of technology in health care expenditure in the EU," European Economy - Economic Papers 2008 - 2015 400, Directorate General Economic and Financial Affairs (DG ECFIN), European Commission.
    14. Peter Willemé & Michel Dumont, 2016. "Machines that go ‘ping’: Medical Technology and Health Expenditures in OECD Countries," Health Economics, John Wiley & Sons, Ltd., vol. 25(3), pages 387-388, March.
    15. Monica Plechero & Claudio Cozza & Raquel Ortega-Argiles, 2017. "European Disparities in Regional Health R&I Performance," Working Papers 13, Department of Management, Università Ca' Foscari Venezia.
    16. Mousnad, Mohamed Awad & Shafie, Asrul Akmal & Ibrahim, Mohamed Izham, 2014. "Systematic review of factors affecting pharmaceutical expenditures," Health Policy, Elsevier, vol. 116(2), pages 137-146.
    17. Fraeyman, Jessica & Symons, Linda & De Loof, Hans & De Meyer, Guido R.Y. & Remmen, Roy & Beutels, Philippe & Van Hal, Guido, 2015. "Medicine price awareness in chronic patients in Belgium," Health Policy, Elsevier, vol. 119(2), pages 217-223.
    18. Fabio Pammolli & Massimo Riccaboni & Laura Magazzini, 2012. "The sustainability of European health care systems: beyond income and aging," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(5), pages 623-634, October.
    19. Viktor Chuzhykov & Areg Movsesyan, 2020. "Peculiarities of the Ukrainian medical device market," Business Management, D. A. Tsenov Academy of Economics, Svishtov, Bulgaria, issue 2 Year 20, pages 25-37.
    20. Luca Iaboli & Luana Caselli & Angelina Filice & Gianpaolo Russi & Eleonora Belletti, 2010. "The Unbearable Lightness of Health Science Reporting: A Week Examining Italian Print Media," PLOS ONE, Public Library of Science, vol. 5(3), pages 1-6, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:28:y:2010:i:5:p:429-438. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.